ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRX Proximagen Grp

365.25
0.00 (0.00%)
12 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proximagen Grp LSE:PRX London Ordinary Share GB00B06FMX57 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 365.25 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Proximagen Group PLC Holding(s) in Company (2657I)

23/07/2012 12:29pm

UK Regulatory


TIDMPRX

RNS Number : 2657I

Proximagen Group PLC

23 July 2012

 
 
 TR-1:NOTIFICATION OF MAJOR INTEREST IN SHARES 
------------------------------------------------------------------------------------ 
 
 1. Identity of the issuer or the underlying               Proximagen Group plc 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
---------------------------------------------------  ------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights                                      X 
------------------------------------------------------------------------------  ---- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
------------------------------------------------------------------------------  ---- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
------------------------------------------------------------------------------  ---- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------------------  ---- 
 Other (please 
  specify): 
--------------------  --------------------------------------------------------  ---- 
 3. Full name of person(s) subject                Upsher-Smith Laboratories, Inc. 
  to the 
  notification obligation: (iii) 
---------------------------------------------  ------------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
---------------------------------------------  ------------------------------------- 
 5. Date of the transaction and date                        20 July 2012 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
---------------------------------------------  ------------------------------------- 
 6. Date on which issuer notified:                          20 July 2012 
---------------------------------------------  ------------------------------------- 
 7. Threshold(s) that is/are crossed 
  or 
  reached: (vi, vii)                                            15% 
---------------------------------------------  ------------------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------------------- 
 Class/type of    Situation previous                          Resulting situation after the triggering 
 shares            to the triggering                           transaction 
                   transaction 
 if possible 
 using 
 the ISIN CODE 
---------------  ------------------------------------------  ------------------------------------------------------------- 
                  Number                Number                Number         Number of voting        % of voting 
                   of                    of                    of shares      rights                  rights (x) 
                   Shares                Voting 
                                         Rights 
-------------    --------------------  --------------------  -------------  ----------------------  ---------------------- 
                                                              Direct         Direct   Indirect       Direct     Indirect 
                                                                              (xi)     (xii) 
-------------    ----  -----  -------  ---  ------  -------  -------------  -------  -------------  ---------  ----------- 
 GB00B06FMX57     10,015,700            10,015,700            0              0        10,015,700     0%         15.87% 
                 --------------------  --------------------  -------------  -------  -------------  ---------  ----------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of financial      Expiration           Exercise/                       Number of voting             % of voting 
  instrument             date (xiii)          Conversion Period               rights that may              rights 
                                              (xiv)                           be 
                                                                              acquired if the 
                                                                              instrument is 
                                                                              exercised/ converted. 
---------------------  -------------------  ------------------------------  ---------------------------  ----------------- 
 
 
 C: Financial Instruments with similar economic effect to Qualifying 
  Financial Instruments (xv, xvi) 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of        Exercise       Expiration            Exercise/        Number of voting          % of voting 
 financial       price          date (xvii)           Conversion       rights instrument         rights (xix, 
 instrument                                           period           refers to                 xx) 
                                                      (xviii) 
-------------  -------------  --------------------  ---------------  ------------------------  --------------------------- 
                                                                                                Nominal           Delta 
-------------  -------------  --------------------  ---------------  ------------------------  ----------------  --------- 
 
 
 Total (A+B+C) 
-------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                              Percentage of voting rights 
-------------------------------------------------------------------  ----------------------------------------------------- 
 10,015,700                                                           15.87% 
-------------------------------------------------------------------  ----------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights 
  and/or the 
  financial instruments are effectively held, if applicable: (xxi) 
---------------------------------------------------------------------------------- 
 
          USL Pharma International UK Limited is a direct, wholly-owned subsidiary 
                                                of Upsher-Smith Laboratories, Inc. 
 
       Pursuant to the transaction notified in this form, USL Pharma International 
           UK Limited has acquired 10,015,700 shares in Proximagen Group plc (with 
               all voting rights attached thereto) from Upsher-Smith Laboratories, 
                                                                              Inc. 
 
 Proxy Voting: 
---------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
------------------------------------------------------  -------------------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
------------------------------------------------------  -------------------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
------------------------------------------------------  -------------------------- 
 
 
  13. Additional information: 
------------------------------------------  -------------------------------------- 
 14. Contact name:                                    Stephen M. Robinson 
------------------------------------------  -------------------------------------- 
 
 15. Contact telephone number:                                     +1 763 315 2000 
------------------------------------------  -------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUOUARUWABUAR

1 Year Proximagen Neuroscience Chart

1 Year Proximagen Neuroscience Chart

1 Month Proximagen Neuroscience Chart

1 Month Proximagen Neuroscience Chart

Your Recent History

Delayed Upgrade Clock